Blood Hemolysis Analyzer Using Optical Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring hemoglobin concentration in bodily fluids require erythrocyte removal through centrifugation, limiting speed and accessibility, and do not directly assess erythrocyte membrane fragility without chemical reactions.
Innovation Solution
A system and method using a light source emitting wavelengths of 390-460 nm to detect light absorption by both cell-free and erythrocyte-bound hemoglobin, allowing for non-invasive measurement of hemoglobin concentration and erythrocyte membrane fragility without erythrocyte removal, utilizing absorption detectors and processors to compare light absorption at multiple wavelengths.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If centrifugation is used to remove erythrocytes before hemoglobin measurement, then measurement accuracy is improved, but analysis time increases and accessibility decreases
Solution Approach 1:
The patent extracts only the necessary measurement function from the complex centrifugation process. By using a light source to illuminate the sample and detectors to measure light absorption at specific wavelengths, the system directly measures hemoglobin concentration without extracting or separating erythrocytes, thus eliminating the time-consuming centrifugation step while maintaining measurement capability
Solution Approach 2:
The patent replaces the mechanical centrifugation system with an optical measurement system. Instead of using mechanical force to separate cells from plasma, the system uses light absorption properties to directly quantify hemoglobin in whole blood, substituting a complex mechanical separation process with a simpler optical detection method
2Measurement precision
If centrifugation and chemical reactions are used for hemoglobin measurement, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent extracts the essential measurement function from the complex laboratory setup. By focusing solely on light absorption measurement at specific wavelengths, the system removes the need for centrifugation equipment, chemical reagents, and complex enzymatic reaction systems, achieving hemoglobin measurement with minimal equipment
Solution Approach 2:
The patent replaces mechanical and chemical measurement systems with an optical system. Instead of using centrifuges, chemical substrates, and enzymatic reactions, the invention uses light sources and photodetectors to directly measure hemoglobin concentration, significantly simplifying the device requirements
3Measurement precision
If traditional spectrophotometric methods are used, then hemoglobin concentration can be measured, but erythrocyte membrane fragility cannot be directly assessed
Solution Approach 1:
The patent creates a multi-functional measurement system that can assess both hemoglobin concentration and erythrocyte membrane fragility using the same optical apparatus. By analyzing light absorption characteristics and patterns, the system derives multiple physiological parameters from a single measurement setup, enabling both concentration quantification and membrane integrity evaluation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, non-invasive measurement of cell-free hemoglobin concentration and erythrocyte membrane fragility, overcoming the limitations of existing methods by differentiating between cell-free and erythrocyte-bound hemoglobin, and assessing membrane integrity without the need for centrifugation or chemical reactions.
Implementation Method 1
A first portion of the light is absorbed by the cell-free Hb derivatives and a second portion is absorbed by the Hb derivatives contained within the erythrocytes
Data Source
AI summary
Systems and methods for determining the concentration of hemoglobin derivatives in bodily fluids include devices for measuring and comparing the absorption of electromagnetic radiation by cellular and cell-free hemoglobin at two or more wavelengths in the Soret region. Systems and methods for determining erythrocyte membrane fragility include devices for measuring the concentration of at least one cell-free hemoglobin derivative, and using the absorption properties of cellular and cell-free hemoglobin derivatives in the Soret region.


